Reactions Weekly

, Volume 1182, Issue 1, pp 3–3 | Cite as

How serious is heart failure risk with pioglitazone?

Clinical study
  • 7 Downloads

Keywords

Public Health Adverse Event Placebo Heart Failure Placebo Group 

REFERENCE

  1. 1.
    Erdmann E, Charbonnel B, Wilcox RG, Skene AM, Massi-Benedetti M, Yates J, Tan M, Spanheimer R, Standl E, Dormandy JA, PROactive investigators.Pioglitazone use and heart failure in patients with type 2 diabetes and preexisting cardiovascular disease: data from the PROactive Study (PROactive 08). Diabetes Care 30: 2773-2778, No. 11, Nov 2007Google Scholar

Copyright information

© Adis International limited or Adis Data Information BV 2007

Personalised recommendations